These results demonstrate that decreased neuronal complexity is also observed in a second, mechanistically distinct model of migraine, and that HDAC6 inhibition can prevent these changes in neuronal cytoarchitecture and decrease CSD events. Here, HDAC6 is linked to migraine disorder.